Prostate Cancer News

September Is National Prostate Cancer Awareness Month (08/29/2008)
As the month of September brings prostate cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated prostate cancer information throughout the year.

Preventive Dental Care Reduces Osteonecrosis of the Jaw Associated with Bisphosphonates (08/20/2008)
Patients who undergo preventive dental care prior to receiving therapy with bisphosphonates have a significantly reduced risk of developing osteonecrosis of the jaw. These results were published in an early online publication in the Annals of Oncology.

Initial Radical Prostatectomy Reduces Prostate Cancer Deaths (08/18/2008)
Patients with early prostate cancer who are treated with initial surgery appear to have reduced death from prostate cancer compared with those who undergo watchful waiting as initial therapy. These results were recently published in the Journal of the National Cancer Institute.

Gene-based Test Available to Detect Prostate Cancer (08/07/2008)
A gene-based molecular diagnostic test used to detect prostate cancer has completed the clinical trials process and is ready for commercial use in patients who are at a high risk for the disease. These results were recently released in a press release by Health Discovery Corporation.

U.S. Preventive Services Task Force Does Not Recommend PSA Screening in Elderly Men (08/05/2008)
Members of the U.S. Preventive Services Task Force have concluded that there is still insufficient evidence to recommend PSA screening in men 75 years of age or younger. The details of these recommendations were published in the August 5, 2008 issue of the Annals of Internal Medicine.

More...

Screening/Prevention

September Is National Prostate Cancer Awareness Month (08/29/2008)
As the month of September brings prostate cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated prostate cancer information throughout the year.

Gene-based Test Available to Detect Prostate Cancer (08/07/2008)
A gene-based molecular diagnostic test used to detect prostate cancer has completed the clinical trials process and is ready for commercial use in patients who are at a high risk for the disease. These results were recently released in a press release by Health Discovery Corporation.

U.S. Preventive Services Task Force Does Not Recommend PSA Screening in Elderly Men (08/05/2008)
Members of the U.S. Preventive Services Task Force have concluded that there is still insufficient evidence to recommend PSA screening in men 75 years of age or younger. The details of these recommendations were published in the August 5, 2008 issue of the Annals of Internal Medicine.

Finasteride May Prevent Prostate Cancer Without Increased Risk of Aggressive Cancers (06/26/2008)
Treatment with finasteride for seven years reduced the incidence of prostate cancer by approximately 25% without increasing the incidence of aggressive prostate cancers. These findings, which included a reanalysis of previously reported results, were published in Cancer Prevention Research.

Specific Gene Expression Predicts Risk for Prostate Cancer (05/05/2008)
Expression of the PTOV1 gene helps predict the likelihood of the development of prostate cancer among men with high-grade prostatic intraepithelial neoplasia (HG-PIN). These results were recently published in the journal Clinical Cancer Research.

More...

Early Stage I-II (A-B)

September Is National Prostate Cancer Awareness Month (08/29/2008)
As the month of September brings prostate cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated prostate cancer information throughout the year.

Initial Radical Prostatectomy Reduces Prostate Cancer Deaths (08/18/2008)
Patients with early prostate cancer who are treated with initial surgery appear to have reduced death from prostate cancer compared with those who undergo watchful waiting as initial therapy. These results were recently published in the Journal of the National Cancer Institute.

Denosumab Improves Bone Density in Prostate Cancer Patients (07/14/2008)
In a Phase III clinical trial among men receiving androgen-deprivation therapy for nonmetastatic prostate cancer, treatment with investigational drug denosumab improved bone density and reduced the risk of vertebral fractures.

Immediate Hormone Therapy May Not Improve Outcomes in Elderly Men with Prostate Cancer (07/10/2008)
Treatment with immediate hormone therapy may not improve outcomes compared with conservative management among elderly men with prostate cancer. These results were recently published in the Journal of the American Medical Association.

Updates in the Management of Prostate and Kidney Cancers (05/07/2008)
A report from the 2008 ASCO Genitourinary Cancers Symposium

More...

Locally Advanced Stage III (C)

September Is National Prostate Cancer Awareness Month (08/29/2008)
As the month of September brings prostate cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated prostate cancer information throughout the year.

Initial Radical Prostatectomy Reduces Prostate Cancer Deaths (08/18/2008)
Patients with early prostate cancer who are treated with initial surgery appear to have reduced death from prostate cancer compared with those who undergo watchful waiting as initial therapy. These results were recently published in the Journal of the National Cancer Institute.

Denosumab Improves Bone Density in Prostate Cancer Patients (07/14/2008)
In a Phase III clinical trial among men receiving androgen-deprivation therapy for nonmetastatic prostate cancer, treatment with investigational drug denosumab improved bone density and reduced the risk of vertebral fractures.

Fareston® Decreases Spinal Fractures in Men with Prostate Cancer (06/10/2008)
Among prostate cancer patients receiving androgen deprivation therapy (ADT), treatment with Fareston® (toremifene citrate) reduces the risk of new spinal fractures. These results were presented at the 2008 annual meeting of the American Association for Cancer Research.

Updates in the Management of Prostate and Kidney Cancers (05/07/2008)
A report from the 2008 ASCO Genitourinary Cancers Symposium

More...

Metastatic Stage IV (D)

September Is National Prostate Cancer Awareness Month (08/29/2008)
As the month of September brings prostate cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated prostate cancer information throughout the year.

Preventive Dental Care Reduces Osteonecrosis of the Jaw Associated with Bisphosphonates (08/20/2008)
Patients who undergo preventive dental care prior to receiving therapy with bisphosphonates have a significantly reduced risk of developing osteonecrosis of the jaw. These results were published in an early online publication in the Annals of Oncology.

Radiofrequency Ablation Effective for Primary Lung Tumors and Lung Metastases from Prostate Cancer (08/01/2008)
The use of radiofrequency ablation for the treatment of lung cancer and lung metastases from breast, colon, and prostate cancers and melanoma is effective and safe for some patients. These results were recently published in the Lancet Oncology.

Bone Marker Associated with Survival in Breast, Prostate, and Lung Cancers (06/23/2008)
The bone marker N-telopeptide of type I collagen (NTX) is associated with skeletal-related events and survival among patients with cancer that has spread to the bone (bone metastases).  Improved outcomes may be achieved by reducing these markers through treatment with agents such as Zometa® (zoledronic acid). These results were recently published in the journal Cancer.

Fareston® Decreases Spinal Fractures in Men with Prostate Cancer (06/10/2008)
Among prostate cancer patients receiving androgen deprivation therapy (ADT), treatment with Fareston® (toremifene citrate) reduces the risk of new spinal fractures. These results were presented at the 2008 annual meeting of the American Association for Cancer Research.

More...

Refactory/Recurrent

September Is National Prostate Cancer Awareness Month (08/29/2008)
As the month of September brings prostate cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options, and resources that offer updated prostate cancer information throughout the year.

Preventive Dental Care Reduces Osteonecrosis of the Jaw Associated with Bisphosphonates (08/20/2008)
Patients who undergo preventive dental care prior to receiving therapy with bisphosphonates have a significantly reduced risk of developing osteonecrosis of the jaw. These results were published in an early online publication in the Annals of Oncology.

Novel Agent May Be Effective in Blocking Hormones in Prostate Cancer (07/29/2008)
The novel agent abiraterone, which is still in early-phase clinical trials, may provide anti-cancer responses in patients whose prostate cancer progressed following androgen deprivation therapy. These results were recently published in the Journal of Clinical Oncology.

Bone Marker Associated with Survival in Breast, Prostate, and Lung Cancers (06/23/2008)
The bone marker N-telopeptide of type I collagen (NTX) is associated with skeletal-related events and survival among patients with cancer that has spread to the bone (bone metastases).  Improved outcomes may be achieved by reducing these markers through treatment with agents such as Zometa® (zoledronic acid). These results were recently published in the journal Cancer.

Salvage Radiotherapy Improves Prostate Cancer-specific Survival (06/24/2008)
Radiation therapy following a recurrence of prostate cancer may reduce deaths specifically caused by the disease. These results were recently published in the Journal of the American Medical Association.

More...